Cerity Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.09M | Buy |
165,431
+80,599
| +95% | +$4.43M | 0.02% | 571 |
|
|
2025
Q1 | $6M | Buy |
84,832
+56,897
| +204% | +$4.02M | 0.01% | 665 |
|
|
2024
Q4 | $1.86M | Sell |
27,935
-3,376
| -11% | -$225K | ﹤0.01% | 1135 |
|
|
2024
Q3 | $2.2M | Buy |
31,311
+23,683
| +310% | +$1.66M | ﹤0.01% | 1050 |
|
|
2024
Q2 | $628K | Buy |
7,628
+634
| +9% | +$52.2K | ﹤0.01% | 1433 |
|
|
2024
Q1 | $611K | Buy |
6,994
+3,891
| +125% | +$340K | ﹤0.01% | 1505 |
|
|
2023
Q4 | $299K | Buy |
+3,103
| New | +$299K | ﹤0.01% | 1510 |
|
|
2023
Q3 | – | Sell |
-3,935
| Closed | -$341K | – | 1422 |
|
|
2023
Q2 | $341K | Buy |
3,935
+215
| +6% | +$18.6K | ﹤0.01% | 1339 |
|
|
2023
Q1 | $362K | Buy |
3,720
+389
| +12% | +$37.8K | ﹤0.01% | 1446 |
|
|
2022
Q4 | $345K | Buy |
3,331
+480
| +17% | +$49.7K | ﹤0.01% | 1093 |
|
|
2022
Q3 | $242K | Sell |
2,851
-445
| -14% | -$37.8K | ﹤0.01% | 988 |
|
|
2022
Q2 | $273K | Buy |
+3,296
| New | +$273K | ﹤0.01% | 940 |
|
|
2022
Q1 | – | Sell |
-2,301
| Closed | -$205K | – | 954 |
|
|
2021
Q4 | $205K | Buy |
+2,301
| New | +$205K | ﹤0.01% | 925 |
|
|
2019
Q3 | – | Sell |
-2,439
| Closed | -$209K | – | 478 |
|
|
2019
Q2 | $209K | Buy |
2,439
+16
| +0.7% | +$1.37K | 0.01% | 447 |
|
|
2019
Q1 | $215K | Sell |
2,423
-158
| -6% | -$14K | 0.01% | 486 |
|
|
2018
Q4 | $220K | Buy |
2,581
+103
| +4% | +$8.78K | 0.01% | 464 |
|
|
2018
Q3 | $240K | Sell |
2,478
-38
| -2% | -$3.68K | 0.02% | 474 |
|
|
2018
Q2 | $237K | Sell |
2,516
-2,035
| -45% | -$192K | 0.02% | 480 |
|
|
2018
Q1 | $369K | Sell |
4,551
-79
| -2% | -$6.41K | 0.03% | 387 |
|
|
2017
Q4 | $413K | Sell |
4,630
-235
| -5% | -$21K | 0.03% | 371 |
|
|
2017
Q3 | $453K | Sell |
4,865
-95
| -2% | -$8.85K | 0.03% | 337 |
|
|
2017
Q2 | $450K | Sell |
4,960
-2,418
| -33% | -$219K | 0.04% | 240 |
|
|
2017
Q1 | $648K | Buy |
+7,378
| New | +$648K | 0.05% | 232 |
|